MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kunze, D. L.
Right arrow Articles by Rampe, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kunze, D. L.
Right arrow Articles by Rampe, D.

Characterization of the effects of a new Ca2+ channel activator, FPL 64176, in GH3 cells

DL Kunze and D Rampe

Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas 77030.

We examined the effects of the benzolpyrrole-type Ca2+ channel activator FPL 64176 on voltage-dependent L-type Ca2+ channels in rat anterior pituitary (GH3) cells. FPL 64176 increased K(+)-dependent Ca2+ influx into GH3 cells with an EC50 value of 1.2 x 10(-7) M but had no effect on the binding of [3H]PN200-110 to GH3 cell membranes at concentrations up to 10(-6) M. Whole-cell patch-clamp electrophysiology revealed that FPL 64176 (1 microM) increased L-type Ca2+ channel current amplitude and shifted the current-voltage relationship in the hyperpolarizing direction. Furthermore, Ca2+ channel current activation and deactivation were prolonged. Single-channel analysis showed that FPL 64176 increased both the probability of channel opening and the mean channel open time. Interestingly, the effect of FPL 64176 on channel open time was highly voltage dependent, with much longer openings being observed at more hyperpolarized potentials. We conclude that FPL 64176 represents a new class of L-type Ca2+ channel activator with a novel site and mechanism of action.

Volume 42, Issue 4, pp. 666-670, 10/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Biophys. JHome page
S. I. McDonough, Y. Mori, and B. P. Bean
FPL 64176 Modification of CaV1.2 L-Type Calcium Channels: Dissociation of Effects on Ionic Current and Gating Current
Biophys. J., January 1, 2005; 88(1): 211 - 223.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Yamaguchi, B. S. Zhorov, K. Yoshioka, T. Nagao, H. Ichijo, and S. Adachi-Akahane
Key Roles of Phe1112 and Ser1115 in the Pore-Forming IIIS5-S6 Linker of L-Type Ca2+ Channel {alpha}1C Subunit (CaV 1.2) in Binding of Dihydropyridines and Action of Ca2+ Channel Agonists
Mol. Pharmacol., August 1, 2003; 64(2): 235 - 248.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. M. Janczewski, E. G. Lakatta, and M. D. Stern
Voltage-independent changes in L-type Ca2+ current uncoupled from SR Ca2+ release in cardiac myocytes
Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H2024 - H2031.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
U. Kreuzberg, P. Theissen, H. Schicha, F. Schroder, U. Mehlhorn, E. R. de Vivie, P. Boknik, J. Neumann, C. Grohe, and S. Herzig
Single-channel activity and expression of atrial L-type Ca2+ channels in patients with latent hyperthyroidism
Am J Physiol Heart Circ Physiol, March 1, 2000; 278(3): H723 - H730.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. M Bers and E. Perez-Reyes
Ca channels in cardiac myocytes: structure and function in Ca influx and intracellular Ca release
Cardiovasc Res, May 1, 1999; 42(2): 339 - 360.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. S. K. Sham, L.-S. Song, Y. Chen, L.-H. Deng, M. D. Stern, E. G. Lakatta, and H. Cheng
Termination of Ca2+ release by a local inactivation of ryanodine receptors in cardiac myocytes
PNAS, December 8, 1998; 95(25): 15096 - 15101.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. G. White, M. A. Crumling, and S. D. Meriney
Developmental Changes in Calcium Current Pharmacology and Somatostatin Inhibition in Chick Parasympathetic Neurons
J. Neurosci., August 15, 1997; 17(16): 6302 - 6313.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
S.-W. Jeong and R. D. Wurster
Calcium Channel Currents in Acutely Dissociated Intracardiac Neurons From Adult Rats
J Neurophysiol, April 1, 1997; 77(4): 1769 - 1778.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Mitterdorfer, Z. Wang, M. J. Sinnegger, S. Hering, J. Striessnig, M. Grabner, and H. Glossmann
Two Amino Acid Residues in the IIIS5 Segment of L-Type Calcium Channels Differentially Contribute to 1,4-Dihydropyridine Sensitivity
J. Biol. Chem., November 29, 1996; 271(48): 30330 - 30335.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L.-S. Song, S.-Q. Wang, R.-P. Xiao, H. Spurgeon, E. G. Lakatta, and H. Cheng
{beta}-Adrenergic Stimulation Synchronizes Intracellular Ca2+ Release During Excitation-Contraction Coupling in Cardiac Myocytes
Circ. Res., April 27, 2001; 88(8): 794 - 801.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1992 by the American Society for Pharmacology and Experimental Therapeutics